#METABOLOMICS WORKBENCH araskind_20170619_114448 DATATRACK_ID:1003 STUDY_ID:ST000706 ANALYSIS_ID:AN001097 PROJECT_ID:PR000503
VERSION             	1
CREATED_ON             	July 2, 2017, 11:07 am
#PROJECT
PR:PROJECT_TITLE                 	Effect of DASH Diet on Gut Microbiome
PR:PROJECT_TYPE                  	MS analysis
PR:PROJECT_SUMMARY               	Effect of DASH Diet on Gut Microbiome
PR:INSTITUTE                     	Morehouse School of Medicine
PR:DEPARTMENT                    	Clinical Research Center
PR:LABORATORY                    	Umeakunne Lab
PR:LAST_NAME                     	Umeakunne
PR:FIRST_NAME                    	Kayellen
PR:ADDRESS                       	Atlanta, GA
PR:EMAIL                         	kumeakunne@msm.edu
PR:PHONE                         	404-752-1010
#STUDY
ST:STUDY_TITLE                   	Effect of DASH Diet on Gut Microbiome (SCFA from stool)
ST:STUDY_TYPE                    	MS analysis
ST:STUDY_SUMMARY                 	This research will examine the effect of the currently recommended DASH diet
ST:STUDY_SUMMARY                 	versus a Vegetarian DASH diet on the gut microbiome and risk for cardiovascular
ST:STUDY_SUMMARY                 	disease in pre-hypertensive obese African American women. We will define the gut
ST:STUDY_SUMMARY                 	microbiota profile, short chain fatty acid production, breath hydrogen/methane
ST:STUDY_SUMMARY                 	response, plasma lipopolysaccharide production and other biomarkers of
ST:STUDY_SUMMARY                 	inflammation in response to diet type in obese African American pre-hypertensive
ST:STUDY_SUMMARY                 	females at baseline and following placement on the traditional DASH plan or DASH
ST:STUDY_SUMMARY                 	Vegetarian diet. We will also define these parameters in African American women
ST:STUDY_SUMMARY                 	adhering to a Vegetarian or Vegan Diet. Our goal is to determine how the gut
ST:STUDY_SUMMARY                 	microbiome modulates host physiology and immune function in response to diet
ST:STUDY_SUMMARY                 	type. By evaluating the effect of a recommended DASH dietary pattern versus a
ST:STUDY_SUMMARY                 	Vegetarian DASH plan on the gut microbiome and its fermentation products, we aim
ST:STUDY_SUMMARY                 	to identify novel information about how these diet types strategically reduce
ST:STUDY_SUMMARY                 	cardiovascular disease risk through gut:microbiota:host interaction.
ST:INSTITUTE                     	University of Michigan
ST:DEPARTMENT                    	Biomedical Research Core Facilities
ST:LABORATORY                    	Metabolomics core
ST:LAST_NAME                     	Kachman
ST:FIRST_NAME                    	Maureen
ST:ADDRESS                       	6300 Brehm Tower, 1000 Wall Street, Ann Arbor, MI 48105-5714
ST:EMAIL                         	mkachman@med.umich.edu
ST:PHONE                         	(734) 232-8175
ST:NUM_GROUPS                    	5
ST:TOTAL_SUBJECTS                	13
ST:STUDY_COMMENTS                	We will define the gut microbiota profile, short chain fatty acid production,
ST:STUDY_COMMENTS                	breath hydrogen/methane response, plasma lipopolysaccharide production and other
ST:STUDY_COMMENTS                	biomarkers of inflammation in response to diet type in obese African American
ST:STUDY_COMMENTS                	pre-hypertensive females at baseline and following placement on the traditional
ST:STUDY_COMMENTS                	DASH plan or DASH Vegetarian diet. We will also define these parameters in
ST:STUDY_COMMENTS                	African American women adhering to a Vegetarian or Vegan Diet. Our goal is to
ST:STUDY_COMMENTS                	determine how the gut microbiome modulates host physiology and immune function
ST:STUDY_COMMENTS                	in response to diet type. By evaluating the effect of a recommended DASH dietary
ST:STUDY_COMMENTS                	pattern versus a Vegetarian DASH plan on the gut microbiome and its fermentation
ST:STUDY_COMMENTS                	products, we aim to identify novel information about how these diet types
ST:STUDY_COMMENTS                	strategically reduce cardiovascular disease risk through gut:microbiota:host
ST:STUDY_COMMENTS                	interaction.
#SUBJECT
SU:SUBJECT_TYPE                  	Human
SU:SUBJECT_SPECIES               	Homo sapiens
SU:TAXONOMY_ID                   	9606
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Additional sample data
SUBJECT_SAMPLE_FACTORS           	SU0013361	S00019911	GROUP:pre-hypertensive | Timepoint:Baseline	
SUBJECT_SAMPLE_FACTORS           	SU0013361	S00019912	GROUP:pre-hypertensive | Timepoint:Final	
SUBJECT_SAMPLE_FACTORS           	SU0013362	S00019913	GROUP:pre-hypertensive | Timepoint:Baseline	
SUBJECT_SAMPLE_FACTORS           	SU0013362	S00019914	GROUP:pre-hypertensive | Timepoint:Final	
SUBJECT_SAMPLE_FACTORS           	SU0013363	S00019915	GROUP:vegetarian | Timepoint:NA	
SUBJECT_SAMPLE_FACTORS           	SU0013364	S00019916	GROUP:vegetarian | Timepoint:NA	
SUBJECT_SAMPLE_FACTORS           	SU0013365	S00019917	GROUP:vegetarian | Timepoint:NA	
SUBJECT_SAMPLE_FACTORS           	SU0013366	S00019918	GROUP:vegetarian | Timepoint:NA	
SUBJECT_SAMPLE_FACTORS           	SU0013367	S00019919	GROUP:vegetarian | Timepoint:NA	
SUBJECT_SAMPLE_FACTORS           	SU0013368	S00019920	GROUP:vegetarian | Timepoint:NA	
SUBJECT_SAMPLE_FACTORS           	SU0013369	S00019921	GROUP:vegetarian | Timepoint:NA	
SUBJECT_SAMPLE_FACTORS           	SU0013370	S00019922	GROUP:vegetarian | Timepoint:NA	
SUBJECT_SAMPLE_FACTORS           	SU0013371	S00019923	GROUP:vegetarian | Timepoint:NA	
SUBJECT_SAMPLE_FACTORS           	SU0013372	S00019924	GROUP:vegetarian | Timepoint:NA	
SUBJECT_SAMPLE_FACTORS           	SU9999996	S00020331	GROUP:- | Timepoint:-	
#COLLECTION
CO:COLLECTION_SUMMARY             	-
#TREATMENT
TR:TREATMENT_SUMMARY              	-
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY             	-
SP:SAMPLEPREP_PROTOCOL_FILENAME   	A007 - Short Chain Fatty Acids.pdf
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_TYPE           	GC
CH:INSTRUMENT_NAME               	Agilent 7890N
CH:COLUMN_NAME                   	Phenomenex Zebron ZB-WAXplus (30m x 0.25mm, 0.25um)
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
AN:ANALYSIS_PROTOCOL_FILE        	A007 - Short Chain Fatty Acids.pdf
#MS
MS:MS_COMMENTS                   	-
MS:INSTRUMENT_NAME               	Agilent 5975
MS:INSTRUMENT_TYPE               	Single quadrupole
MS:MS_TYPE                       	EI
MS:ION_MODE                      	POSITIVE
#MS_METABOLITE_DATA
MS_METABOLITE_DATA:UNITS         	nmol/mg
MS_METABOLITE_DATA_START
Samples	S00019911	S00019912	S00019913	S00019914	S00019915	S00019916	S00019917	S00019918	S00019919	S00019920	S00019921	S00019922	S00019923	S00019924
Factors	GROUP:pre-hypertensive | Timepoint:Baseline	GROUP:pre-hypertensive | Timepoint:Final	GROUP:pre-hypertensive | Timepoint:Baseline	GROUP:pre-hypertensive | Timepoint:Final	GROUP:vegetarian | Timepoint:NA	GROUP:vegetarian | Timepoint:NA	GROUP:vegetarian | Timepoint:NA	GROUP:vegetarian | Timepoint:NA	GROUP:vegetarian | Timepoint:NA	GROUP:vegetarian | Timepoint:NA	GROUP:vegetarian | Timepoint:NA	GROUP:vegetarian | Timepoint:NA	GROUP:vegetarian | Timepoint:NA	GROUP:vegetarian | Timepoint:NA
PROPIONIC ACID	8.852236798	11.27271996	17.03812961	14.78126926	16.36067918	13.96667136	16.44197152	8.884039523	9.481304533	17.32633263	28.31857223	14.32819129	13.30631982	19.99695861
ISOVALERIC ACID	3.457113334	3.625089679	2.291167277	2.779638021	2.181763109	3.057268574	3.120600567	2.41064069	6.203278222	2.733310428	3.791872433	2.8387834	2.158547839	3.654262637
ACETIC ACID	18.56150626	26.61320737	42.68108337	39.37739033	35.95992971	50.69160271	65.33690694	64.04033935	51.95017774	53.32053031	59.27061884	39.8394841	70.73166133	56.88307069
BUTYRIC ACID	6.915580233	10.13901386	15.81784213	10.65616711	10.08362003	15.02419468	10.23049748	11.54838117	11.33329436	15.52744651	15.1886497	10.21575242	13.58832323	11.69908892
VALERIC ACID	3.577568723	3.88116141	2.201813285	2.783312711	2.817962031	3.882171896	3.706071313	2.95050583	6.367080467	3.280202867	4.69186696	3.418173322	2.516136008	4.785035801
HEPTANOIC ACID	.036158188	.029603602	.025142999	.031193913	.020295859	.11874462	.032062447	.023965516	.030655009	.024707107	.032089551	.081992259	.024006212	.02338342
HEXANOIC ACID	.66161492	.542445035	.449052572	.589460473	.39309608	1.838362861	.639891077	.45582264	.559459378	.476105594	.6042068	1.193949944	.460094135	.450508403
MS_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name	moverz_quant	ri	ri_type	pubchem_id	inchi_key	kegg_id	other_id	other_id_type
PROPIONIC ACID				1032
ISOVALERIC ACID				10430
ACETIC ACID				176
BUTYRIC ACID				264
VALERIC ACID				7991
HEPTANOIC ACID				8094
HEXANOIC ACID				8892
METABOLITES_END
#END